CAS: 264233-05-8
Ref: AN-AG00C2VK
| 5mg | 242,00 € | |
| 25mg | A consultar |
Entrega estimada em Estados Unidos, Quinta-feira 23 de Maio de 2024
CID 2745687
CAS:264233-05-8
CID 2745687 is a GPR35 antagonist that inhibited the effects at human GPR35 of cromolyn …
Fórmula:
C17H19F2N5O2S
Pureza:
99.11%
Cor e Forma:
Solid
Peso molecular:
395.43
Ref: TM-T21874
| 1mg | 40,00 € | |
| 2mg | 52,00 € | |
| 5mg | 87,00 € | |
| 10mg | 123,00 € | |
| 25mg | 269,00 € | |
| 50mg | 423,00 € | |
| 100mg | 628,00 € | |
| 1ml*10 (DMSO) | 96,00 € |
Entrega estimada em Estados Unidos, Quinta-feira 30 de Maio de 2024
Methyl 1-(2,4-Difluoro-phenyl)-5-((4-tert-butyl-thiosemicarbazono)methyl)-1H-pyrazole-4-carboxylate
CAS:264233-05-8
Applications Used as a GPR35 antagonist, with potential application towards immune or gastrointestinal system regulation. …
Fórmula:
C17H19F2N5O2S
Peso molecular:
395.427
Ref: TR-M301800
| 250mg | 3.618,00 € |
Entrega estimada em Estados Unidos, Quarta-feira 3 de Julho de 2024
Methyl 1-(2,4-Difluoro-phenyl)-5-((4-tert-butyl-thiosemicarbazono)methyl)-1H-pyrazole-4-carboxylate
CAS:264233-05-8
Methyl 1-(2,4-difluoro-phenyl)-5-((4-tert-butyl-thiosemicarbazono)methyl)-1H-pyrazole-4-carboxylate (SNX-111) is a drug that has been shown to be useful in the …
Fórmula:
C17H19F2N5O2S
Pureza:
Min. 95%
Peso molecular:
395.43 g/mol
Ref: 3D-FM102381
| 100mg | A consultar |
Entrega estimada em Estados Unidos, Sexta-feira 5 de Julho de 2024
